
Asymmetrex Discusses a Near Horizon for Stem Cell Dosage in Stem Cell Therapy and Gene Therapy Clinical Trial Supply Chains
Today, May 11, in the Clinical Trial Supply USA 2021 – Virtual Conference, the President and CEO of stem cell biotechnology company Asymmetrex, James L. Sherley, M.D., Ph.D., discussed new developments on the horizon for the supply chains for stem cell therapy and gene therapy clinical trials. In particular, he suggested that it is inevitable